Page last updated: 2024-11-04

bis(5-amidino-2-benzimidazolyl)methane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2387
CHEMBL ID99951
SCHEMBL ID65730
MeSH IDM0084750

Synonyms (17)

Synonym
bis(5-amidino-2-benzimidazolyl)methane
2-[(5-carbamimidoyl-1h-benzimidazol-2-yl)methyl]-1h-benzimidazole-5-carboxamidine
babim
1C1V ,
1XUG
2,2 -methanediylbis(1h-benzimidazole-6-carboximidamide)
aids007118
bdbm16127
chembl99951 ,
2-[(6-carbamimidoyl-1h-1,3-benzodiazol-2-yl)methyl]-1h-1,3-benzodiazole-6-carboximidamide
74733-75-8
2-[(6-carbamimidoyl-1h-benzimidazol-2-yl)methyl]-3h-benzimidazole-5-carboximidamide
1h-benzimidazole-5-carboximidamide, 2,2'-methylenebis-
1h-benzimidazole-6-carboximidamide,2,2'-methylenebis-
SCHEMBL65730
DTXSID60225717
2,2'-methylenebis(1h-benzo[d]imidazole-5-carboximidamide)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" When animals were immunosuppressed to prolong virus shedding, the reduction in recovered virus achieved with a 7-day dosing schedule of bis(5-amidino-2-benzimidazolyl)methane exceeded 2 logs."( Suppression of respiratory syncytial virus infection in cotton rats by bis(5-amidino-2-benzimidazolyl)methane.
Clyde, WA; Dubovi, EJ; Geratz, JD; Rosenthal, KU; Tidwell, RR, 1984
)
0.7
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (19)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TRYPSINBos taurus (cattle)Ki0.05650.02300.05650.0900AID977610
Chain H, ALPHA THROMBINHomo sapiens (human)Ki0.05650.02300.05650.0900AID977610
Chain H, Thrombin heavy chainHomo sapiens (human)Ki0.05650.02300.05650.0900AID977610
Chain A, TRYPSINBos taurus (cattle)Ki0.05650.02300.05650.0900AID977610
ProthrombinHomo sapiens (human)IC50 (µMol)31.00000.00000.710710.0000AID266449
ProthrombinHomo sapiens (human)Ki238.75990.00000.78469.0000AID1797494
Prothrombin Bos taurus (cattle)Ki4.15000.00112.06948.3700AID1132851; AID213272
Coagulation factor XHomo sapiens (human)IC50 (µMol)4.50000.00030.593710.0000AID266447
Coagulation factor XHomo sapiens (human)Ki238.75990.00000.47089.0000AID1797494
PlasminogenHomo sapiens (human)IC50 (µMol)26.00000.02503.628010.0000AID266448
PlasminogenHomo sapiens (human)Ki2.47500.01701.15604.4000AID157985; AID1797470
Urokinase-type plasminogen activatorHomo sapiens (human)Ki2.31500.01702.62687.0000AID1797470; AID215664
Tissue-type plasminogen activatorHomo sapiens (human)Ki2.30000.01703.71968.6000AID1797470
Glandular kallikreinSus scrofa (pig)Ki17.30002.70007.10339.5300AID1132853
Cationic trypsinBos taurus (cattle)Ki0.01700.00001.07539.0000AID215197
Trypsin-1Homo sapiens (human)IC50 (µMol)4.40000.00351.532110.0000AID266446
Trypsin-1Homo sapiens (human)Ki206.01490.00001.76768.9000AID1797494; AID643992; AID644011
Trypsin-2Homo sapiens (human)IC50 (µMol)4.40000.00351.58464.4000AID266446
Trypsin-2Homo sapiens (human)Ki9.54500.00430.94873.2900AID643992; AID644011
Tryptase beta-2Homo sapiens (human)Ki238.75990.00101.05323.7000AID1797494
ChymaseHomo sapiens (human)Ki238.75990.00101.05323.7000AID1797494
Trypsin-3Homo sapiens (human)IC50 (µMol)4.40000.00351.58464.4000AID266446
Trypsin-3Homo sapiens (human)Ki9.54500.00430.94873.2900AID643992; AID644011
Tryptase alpha/beta-1Homo sapiens (human)IC50 (µMol)0.05100.00401.438910.0000AID266445
Tryptase alpha/beta-1Homo sapiens (human)Ki0.14000.14000.14000.1400AID238535; AID239009
Chymotrypsin-CHomo sapiens (human)Ki238.75990.00100.92403.7000AID1797494
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (87)

Processvia Protein(s)Taxonomy
positive regulation of protein phosphorylationProthrombinHomo sapiens (human)
proteolysisProthrombinHomo sapiens (human)
acute-phase responseProthrombinHomo sapiens (human)
cell surface receptor signaling pathwayProthrombinHomo sapiens (human)
G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell population proliferationProthrombinHomo sapiens (human)
regulation of cell shapeProthrombinHomo sapiens (human)
response to woundingProthrombinHomo sapiens (human)
negative regulation of platelet activationProthrombinHomo sapiens (human)
platelet activationProthrombinHomo sapiens (human)
regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell growthProthrombinHomo sapiens (human)
positive regulation of insulin secretionProthrombinHomo sapiens (human)
positive regulation of collagen biosynthetic processProthrombinHomo sapiens (human)
fibrinolysisProthrombinHomo sapiens (human)
negative regulation of proteolysisProthrombinHomo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATProthrombinHomo sapiens (human)
negative regulation of astrocyte differentiationProthrombinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolProthrombinHomo sapiens (human)
regulation of cytosolic calcium ion concentrationProthrombinHomo sapiens (human)
cytolysis by host of symbiont cellsProthrombinHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProthrombinHomo sapiens (human)
negative regulation of fibrinolysisProthrombinHomo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptideProthrombinHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumProthrombinHomo sapiens (human)
positive regulation of lipid kinase activityProthrombinHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responseProthrombinHomo sapiens (human)
positive regulation of protein localization to nucleusProthrombinHomo sapiens (human)
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
ligand-gated ion channel signaling pathwayProthrombinHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processProthrombinHomo sapiens (human)
proteolysisProthrombin Bos taurus (cattle)
acute-phase responseProthrombin Bos taurus (cattle)
positive regulation of blood coagulationProthrombin Bos taurus (cattle)
protein polymerizationProthrombin Bos taurus (cattle)
proteolysisCoagulation factor XHomo sapiens (human)
blood coagulationCoagulation factor XHomo sapiens (human)
positive regulation of cell migrationCoagulation factor XHomo sapiens (human)
positive regulation of TOR signalingCoagulation factor XHomo sapiens (human)
proteolysisPlasminogenHomo sapiens (human)
blood coagulationPlasminogenHomo sapiens (human)
negative regulation of cell population proliferationPlasminogenHomo sapiens (human)
negative regulation of cell-substrate adhesionPlasminogenHomo sapiens (human)
extracellular matrix disassemblyPlasminogenHomo sapiens (human)
tissue regenerationPlasminogenHomo sapiens (human)
fibrinolysisPlasminogenHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationPlasminogenHomo sapiens (human)
myoblast differentiationPlasminogenHomo sapiens (human)
muscle cell cellular homeostasisPlasminogenHomo sapiens (human)
tissue remodelingPlasminogenHomo sapiens (human)
biological process involved in interaction with symbiontPlasminogenHomo sapiens (human)
negative regulation of fibrinolysisPlasminogenHomo sapiens (human)
positive regulation of fibrinolysisPlasminogenHomo sapiens (human)
trophoblast giant cell differentiationPlasminogenHomo sapiens (human)
labyrinthine layer blood vessel developmentPlasminogenHomo sapiens (human)
mononuclear cell migrationPlasminogenHomo sapiens (human)
trans-synaptic signaling by BDNF, modulating synaptic transmissionPlasminogenHomo sapiens (human)
negative regulation of cell-cell adhesion mediated by cadherinPlasminogenHomo sapiens (human)
positive regulation of cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisUrokinase-type plasminogen activatorHomo sapiens (human)
chemotaxisUrokinase-type plasminogen activatorHomo sapiens (human)
signal transductionUrokinase-type plasminogen activatorHomo sapiens (human)
blood coagulationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of signaling receptor activityUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesion mediated by integrinUrokinase-type plasminogen activatorHomo sapiens (human)
urokinase plasminogen activator signaling pathwayUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell population proliferationUrokinase-type plasminogen activatorHomo sapiens (human)
fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of wound healingUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaTissue-type plasminogen activatorHomo sapiens (human)
proteolysisTissue-type plasminogen activatorHomo sapiens (human)
blood coagulationTissue-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationTissue-type plasminogen activatorHomo sapiens (human)
plasminogen activationTissue-type plasminogen activatorHomo sapiens (human)
protein modification processTissue-type plasminogen activatorHomo sapiens (human)
fibrinolysisTissue-type plasminogen activatorHomo sapiens (human)
negative regulation of proteolysisTissue-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisTissue-type plasminogen activatorHomo sapiens (human)
prevention of polyspermyTissue-type plasminogen activatorHomo sapiens (human)
trans-synaptic signaling by BDNF, modulating synaptic transmissionTissue-type plasminogen activatorHomo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTissue-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationTissue-type plasminogen activatorHomo sapiens (human)
proteolysisCationic trypsinBos taurus (cattle)
digestionCationic trypsinBos taurus (cattle)
digestionTrypsin-1Homo sapiens (human)
extracellular matrix disassemblyTrypsin-1Homo sapiens (human)
proteolysisTrypsin-1Homo sapiens (human)
proteolysisTrypsin-2Homo sapiens (human)
digestionTrypsin-2Homo sapiens (human)
antimicrobial humoral responseTrypsin-2Homo sapiens (human)
extracellular matrix disassemblyTrypsin-2Homo sapiens (human)
positive regulation of cell growthTrypsin-2Homo sapiens (human)
collagen catabolic processTrypsin-2Homo sapiens (human)
positive regulation of cell adhesionTrypsin-2Homo sapiens (human)
proteolysisTryptase beta-2Homo sapiens (human)
angiotensin maturationChymaseHomo sapiens (human)
peptide metabolic processChymaseHomo sapiens (human)
extracellular matrix disassemblyChymaseHomo sapiens (human)
protein catabolic processChymaseHomo sapiens (human)
midbrain developmentChymaseHomo sapiens (human)
basement membrane disassemblyChymaseHomo sapiens (human)
positive regulation of angiogenesisChymaseHomo sapiens (human)
regulation of inflammatory responseChymaseHomo sapiens (human)
cellular response to glucose stimulusChymaseHomo sapiens (human)
cytokine precursor processingChymaseHomo sapiens (human)
proteolysisTrypsin-3Homo sapiens (human)
digestionTrypsin-3Homo sapiens (human)
antimicrobial humoral responseTrypsin-3Homo sapiens (human)
zymogen activationTrypsin-3Homo sapiens (human)
endothelial cell migrationTrypsin-3Homo sapiens (human)
defense responseTryptase alpha/beta-1Homo sapiens (human)
extracellular matrix disassemblyTryptase alpha/beta-1Homo sapiens (human)
proteolysisTryptase alpha/beta-1Homo sapiens (human)
proteolysisChymotrypsin-CHomo sapiens (human)
intracellular calcium ion homeostasisChymotrypsin-CHomo sapiens (human)
proteolysisChymotrypsin-CHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (26)

Processvia Protein(s)Taxonomy
lipopolysaccharide bindingProthrombinHomo sapiens (human)
serine-type endopeptidase activityProthrombinHomo sapiens (human)
signaling receptor bindingProthrombinHomo sapiens (human)
calcium ion bindingProthrombinHomo sapiens (human)
protein bindingProthrombinHomo sapiens (human)
growth factor activityProthrombinHomo sapiens (human)
heparin bindingProthrombinHomo sapiens (human)
thrombospondin receptor activityProthrombinHomo sapiens (human)
serine-type endopeptidase activityProthrombin Bos taurus (cattle)
calcium ion bindingProthrombin Bos taurus (cattle)
protein bindingProthrombin Bos taurus (cattle)
fibrinogen bindingProthrombin Bos taurus (cattle)
serine-type endopeptidase activityCoagulation factor XHomo sapiens (human)
calcium ion bindingCoagulation factor XHomo sapiens (human)
protein bindingCoagulation factor XHomo sapiens (human)
phospholipid bindingCoagulation factor XHomo sapiens (human)
protease bindingPlasminogenHomo sapiens (human)
endopeptidase activityPlasminogenHomo sapiens (human)
serine-type endopeptidase activityPlasminogenHomo sapiens (human)
signaling receptor bindingPlasminogenHomo sapiens (human)
protein bindingPlasminogenHomo sapiens (human)
serine-type peptidase activityPlasminogenHomo sapiens (human)
enzyme bindingPlasminogenHomo sapiens (human)
kinase bindingPlasminogenHomo sapiens (human)
protein domain specific bindingPlasminogenHomo sapiens (human)
apolipoprotein bindingPlasminogenHomo sapiens (human)
protein-folding chaperone bindingPlasminogenHomo sapiens (human)
protein antigen bindingPlasminogenHomo sapiens (human)
serine-type endopeptidase activityUrokinase-type plasminogen activatorHomo sapiens (human)
protein bindingUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase activityTissue-type plasminogen activatorHomo sapiens (human)
signaling receptor bindingTissue-type plasminogen activatorHomo sapiens (human)
protein bindingTissue-type plasminogen activatorHomo sapiens (human)
phosphoprotein bindingTissue-type plasminogen activatorHomo sapiens (human)
endopeptidase activityCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityCationic trypsinBos taurus (cattle)
protein bindingCationic trypsinBos taurus (cattle)
metal ion bindingCationic trypsinBos taurus (cattle)
serpin family protein bindingCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityTrypsin-1Homo sapiens (human)
metal ion bindingTrypsin-1Homo sapiens (human)
metalloendopeptidase activityTrypsin-2Homo sapiens (human)
serine-type endopeptidase activityTrypsin-2Homo sapiens (human)
calcium ion bindingTrypsin-2Homo sapiens (human)
protein bindingTrypsin-2Homo sapiens (human)
serine-type peptidase activityTrypsin-2Homo sapiens (human)
serine-type endopeptidase activityTryptase beta-2Homo sapiens (human)
protein bindingTryptase beta-2Homo sapiens (human)
serine-type peptidase activityTryptase beta-2Homo sapiens (human)
endopeptidase activityChymaseHomo sapiens (human)
serine-type endopeptidase activityChymaseHomo sapiens (human)
serine-type peptidase activityChymaseHomo sapiens (human)
peptide bindingChymaseHomo sapiens (human)
serine-type endopeptidase activityTrypsin-3Homo sapiens (human)
calcium ion bindingTrypsin-3Homo sapiens (human)
protein bindingTrypsin-3Homo sapiens (human)
serine-type peptidase activityTrypsin-3Homo sapiens (human)
serine-type endopeptidase activityTryptase alpha/beta-1Homo sapiens (human)
protein bindingTryptase alpha/beta-1Homo sapiens (human)
serine-type peptidase activityTryptase alpha/beta-1Homo sapiens (human)
identical protein bindingTryptase alpha/beta-1Homo sapiens (human)
protein bindingChymotrypsin-CHomo sapiens (human)
peptidase activityChymotrypsin-CHomo sapiens (human)
serine-type endopeptidase activityChymotrypsin-CHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (28)

Processvia Protein(s)Taxonomy
external side of plasma membraneProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular regionProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
endoplasmic reticulum lumenProthrombinHomo sapiens (human)
Golgi lumenProthrombinHomo sapiens (human)
plasma membraneProthrombinHomo sapiens (human)
extracellular exosomeProthrombinHomo sapiens (human)
blood microparticleProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
extracellular regionCoagulation factor XHomo sapiens (human)
endoplasmic reticulum lumenCoagulation factor XHomo sapiens (human)
Golgi lumenCoagulation factor XHomo sapiens (human)
plasma membraneCoagulation factor XHomo sapiens (human)
external side of plasma membraneCoagulation factor XHomo sapiens (human)
extracellular spaceCoagulation factor XHomo sapiens (human)
extracellular regionPlasminogenHomo sapiens (human)
extracellular spacePlasminogenHomo sapiens (human)
plasma membranePlasminogenHomo sapiens (human)
external side of plasma membranePlasminogenHomo sapiens (human)
cell surfacePlasminogenHomo sapiens (human)
platelet alpha granule lumenPlasminogenHomo sapiens (human)
collagen-containing extracellular matrixPlasminogenHomo sapiens (human)
extracellular exosomePlasminogenHomo sapiens (human)
blood microparticlePlasminogenHomo sapiens (human)
Schaffer collateral - CA1 synapsePlasminogenHomo sapiens (human)
glutamatergic synapsePlasminogenHomo sapiens (human)
extracellular spacePlasminogenHomo sapiens (human)
extracellular regionUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
focal adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
external side of plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
cell surfaceUrokinase-type plasminogen activatorHomo sapiens (human)
specific granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular exosomeUrokinase-type plasminogen activatorHomo sapiens (human)
tertiary granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexUrokinase-type plasminogen activatorHomo sapiens (human)
protein complex involved in cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase complexUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
collagen-containing extracellular matrixTissue-type plasminogen activatorHomo sapiens (human)
extracellular regionTissue-type plasminogen activatorHomo sapiens (human)
cytoplasmTissue-type plasminogen activatorHomo sapiens (human)
cell surfaceTissue-type plasminogen activatorHomo sapiens (human)
secretory granuleTissue-type plasminogen activatorHomo sapiens (human)
apical part of cellTissue-type plasminogen activatorHomo sapiens (human)
extracellular exosomeTissue-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexTissue-type plasminogen activatorHomo sapiens (human)
Schaffer collateral - CA1 synapseTissue-type plasminogen activatorHomo sapiens (human)
glutamatergic synapseTissue-type plasminogen activatorHomo sapiens (human)
extracellular spaceTissue-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexCationic trypsinBos taurus (cattle)
extracellular regionTrypsin-1Homo sapiens (human)
collagen-containing extracellular matrixTrypsin-1Homo sapiens (human)
blood microparticleTrypsin-1Homo sapiens (human)
extracellular spaceTrypsin-1Homo sapiens (human)
extracellular regionTrypsin-2Homo sapiens (human)
extracellular spaceTrypsin-2Homo sapiens (human)
extracellular matrixTrypsin-2Homo sapiens (human)
azurophil granule lumenTrypsin-2Homo sapiens (human)
extracellular spaceTrypsin-2Homo sapiens (human)
collagen-containing extracellular matrixTryptase beta-2Homo sapiens (human)
extracellular spaceTryptase beta-2Homo sapiens (human)
collagen-containing extracellular matrixChymaseHomo sapiens (human)
extracellular regionChymaseHomo sapiens (human)
cytosolChymaseHomo sapiens (human)
secretory granuleChymaseHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleChymaseHomo sapiens (human)
collagen-containing extracellular matrixChymaseHomo sapiens (human)
extracellular spaceChymaseHomo sapiens (human)
intracellular membrane-bounded organelleChymaseHomo sapiens (human)
cytoplasmChymaseHomo sapiens (human)
extracellular regionTrypsin-3Homo sapiens (human)
extracellular spaceTrypsin-3Homo sapiens (human)
tertiary granule lumenTrypsin-3Homo sapiens (human)
extracellular spaceTrypsin-3Homo sapiens (human)
collagen-containing extracellular matrixTryptase alpha/beta-1Homo sapiens (human)
extracellular regionTryptase alpha/beta-1Homo sapiens (human)
extracellular spaceTryptase alpha/beta-1Homo sapiens (human)
extracellular spaceTryptase alpha/beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (44)

Assay IDTitleYearJournalArticle
AID31892Thermal denaturation in alternating poly(dA-dT)poly(dA-dT) homopolymer (AT)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID266450Inhibition of elastase2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID233022Thermal melting temperature for (dCGCGAATTCGCG)2 at a concentration of 3*10e-6 M base pairs at a ratio of 0.6 compound per base pair1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
AID215197Inhibition constant against bovine trypsin1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
AID233938Ratio between poly-dAdT and poly-dGdC binding1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID1132857Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 10'-5 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs)1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID1132853Competitive reversible inhibition of porcine pancreatic kallikrein using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 180 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID643992Inhibition of human trypsin in presence of Zn2+2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2).
AID81733Minimum concentration required for the complete blockage of virus induced cell division.1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
AID233025Thermal melting temperature determined for poly(dA).poly(dT) at a concentration of 5*10e-5) M base pairs at a ratio of 0.6 compound per base pair1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
AID266445Inhibition of human beta tryptase2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID266449Inhibition of thrombin2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID227749Binding constant obtained in an ethidium displacement assay for the sequence d(CGGAATTCGCG)21996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
AID1132851Competitive reversible inhibition of bovine thrombin using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 40 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID238535In vitro inhibitory activity against tryptase2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase.
AID233024Thermal melting temperature for poly(A).poly(U) at a concentration of 5*10e-5) M base pairs at a ratio of 0.6 compound per base pair1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
AID266451Selectivity for human beta tryptase over trypsin2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID266452Selectivity for human beta tryptase over F10a2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID213272Inhibition constant against bovine thrombin1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
AID1132852Competitive reversible inhibition of bovine trypsin using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 30 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID266448Inhibition of plasmin2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID72882Thermal denaturation in alternating poly(dG-dC)-poly(dG-dC) homopolymer (GC)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID266454Selectivity for human beta tryptase over thrombin2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID157985Inhibition constant against human plasminogen1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
AID266447Inhibition of F10a2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID644011Inhibition of human trypsin in presence of EDTA2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2).
AID42661In vitro inhibitory potency was tested against botulinum neurotoxin/B (BoNT/B) expressed as Ki2003Journal of medicinal chemistry, Oct-23, Volume: 46, Issue:22
Development of potent inhibitors of botulinum neurotoxin type B.
AID266453Selectivity for human beta tryptase over plasmin2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID266446Inhibition of trypsin2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID233023Thermal melting temperature determined for (dG-C)4 at a concentration of 3*10e-6 M base pairs at a ratio of 0.6 compound per base pair1996Journal of medicinal chemistry, Mar-29, Volume: 39, Issue:7
Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
AID215664Inhibition constant against Urokinase1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
AID1132855Competitive reversible inhibition of bovine trypsin using N-benzoyl-L-phenylalanyl-L-valyl-L-arginine-p-nitroanilide hydrochloride as substrate after 15 to 30 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID31893Thermal denaturation in sonicated poly(dA)-poly(dT) homopolymer (AT)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID308545Antiviral activity against RSV long A with F1 protein K394R mutation in HEp2 cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.
AID266455Selectivity for human beta tryptase over elastase2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
AID1132858Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 5 x 10'-6 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs)1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID54984Thermal denaturation in sonicated calf thymus DNA (CT DNA)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID1132856Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 10'-4 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs)1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID239009Inhibitory activity against human Tryptase beta 2 expressed in yeast cells2004Bioorganic & medicinal chemistry letters, Oct-04, Volume: 14, Issue:19
Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1998Nature, Feb-05, Volume: 391, Issue:6667
Design of potent selective zinc-mediated serine protease inhibitors.
AID1811Experimentally measured binding affinity data derived from PDB1998Nature, Feb-05, Volume: 391, Issue:6667
Design of potent selective zinc-mediated serine protease inhibitors.
AID1797494Enzyme Inhibition Assay from Article 10.1038/35422: \\Design of potent selective zinc-mediated serine protease inhibitors.\\1998Nature, Feb-05, Volume: 391, Issue:6667
Design of potent selective zinc-mediated serine protease inhibitors.
AID1797470Determination of Inhibitor Potency and Selectivity from Article 10.1021/jm061066t: \\Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines.\\2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines.
AID493017Wombat Data for BeliefDocking2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (33.33)18.7374
1990's11 (36.67)18.2507
2000's8 (26.67)29.6817
2010's1 (3.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.78 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]